Table 1 Patient baseline and tumor characteristics
Patient baseline and tumor characteristics | |
|---|---|
Sex, n (%) | |
Female | 11 (61.1) |
Male | 7 (38.9) |
Age, years | |
Median | 74 (range 49–92) |
Weight, kg | |
Median | 72 (range 50–145) |
Height, m | |
Median | 1.68 (range 1.50–1.85) |
ECOG (0–5) | |
0 | 18 (100) |
Skin type (Fitzpatrick) | |
2 | 15 (83.3) |
3 | 3 (16.7) |
Histopathological BCC subtype, n (%) | |
Non-infiltrative | 9 (50.0) |
Infiltrative | 9 (50.0) |
BCC ulceration n (%) | |
Yes | 9 (50.0) |
No | 9 (50.0) |
BCC localization, n (%) | |
Head and neck | 13 (72.2) |
Lower extremities | 2 (11.1) |
Trunk | 3 (16.7) |
Longest tumor diameter, cm | |
Median | 1.4 (range 0.7–13.7) |
Recurrent BCC, n (%) | |
Yes | 2 (11.1) |
No | 16 (88.9) |
Previous BCC surgery, n (%) | |
Yes | 2 (11.1) |
No | 16 (88.9) |
Previous BCC therapy, n (%) | |
Yes | 5 (27.8) |
No | 13 (72.2) |
Previous BCC, n (%) | |
Yes | 3 (16.7) |
No | 15 (83.3) |
Previous HSV infection, n (%) | |
Yes | 12 (66.7) |
No | 6 (33.3) |
Previous HSV lesion localization, n (%) | |
Oral | 11 (61.1) |
Oral and genital | 1 (5.6) |
NA | 6 (33.3) |
Serum HSV IgG, n (%) | |
Negative | 1 (5.6) |
Positive | 17 (94.4) |
